Sort by
Refine Your Search
-
Employer
- Institute of Mathematics of the Polish Academy of Sciences
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- AGH University of Krakow
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences
- University of Warsaw: Faculty of Mathematics, Informatics and Mechanics
-
Field
-
17 Oct 2025 Job Information Organisation/Company Institute of Mathematics of the Polish Academy of Sciences Research Field Mathematics Researcher Profile First Stage Researcher (R1) Positions PhD
-
17 Oct 2025 Job Information Organisation/Company Institute of Mathematics of the Polish Academy of Sciences Research Field Mathematics Researcher Profile First Stage Researcher (R1) Positions PhD
-
The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences | Poland | 11 days ago
culture assays and in vivo experiments to apply. Prior expertise in RNA virus infection biology, bioinformatical analysis of proteomic and transcriptomic data, and/or cryo-EM/ET will be considered a strong
-
, item 1571, consolidated text). At the moment of employment, the candidate must hold a PhD degree in mathematics or related fields. The degree must be obtained no earlier than 7 years before the year of
-
Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences | Poland | 27 days ago
Research FieldEngineering » Chemical engineeringEducation LevelPhD or equivalent Skills/Qualifications PhD degree in chemistry, chemical engineering or related disciplines; knowledge of surfactant
-
(R2) Positions PhD Positions Country Poland Application Deadline 5 Oct 2025 - 23:59 (Europe/Warsaw) Type of Contract Temporary Job Status Full-time Offer Starting Date 5 Oct 2025 Is the job funded
-
The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences | Poland | 2 months ago
targets in cancer treatment. Our group wants to understand how aberrant signalling in cancer cells contributes to cancer development, metastasis or therapy resistance, and how we can use that knowledge